SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-115579
Filing Date
2020-10-16
Accepted
2020-10-16 13:05:19
Documents
1
Period of Report
2020-10-15

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 5209
  Complete submission text file 0001104659-20-115579.txt   6650
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Issuer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 7707 FANNIN, SUITE 140 HOUSTON TX 77054
Business Address
Chiriva Internati Maurizio (Reporting) CIK: 0001815884 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39619 | Film No.: 201243523